SI9300584A - Therapeutic agents for treatment of obesity and affective disorders and processes for their preparation - Google Patents

Therapeutic agents for treatment of obesity and affective disorders and processes for their preparation Download PDF

Info

Publication number
SI9300584A
SI9300584A SI9300584A SI9300584A SI9300584A SI 9300584 A SI9300584 A SI 9300584A SI 9300584 A SI9300584 A SI 9300584A SI 9300584 A SI9300584 A SI 9300584A SI 9300584 A SI9300584 A SI 9300584A
Authority
SI
Slovenia
Prior art keywords
azaspiro
formula
carbon atoms
chlorophenyl
ene
Prior art date
Application number
SI9300584A
Other languages
English (en)
Slovenian (sl)
Inventor
Paul John Harris
Frank Kerrigan
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of SI9300584A publication Critical patent/SI9300584A/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20Spiro-condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SI9300584A 1992-11-09 1993-11-09 Therapeutic agents for treatment of obesity and affective disorders and processes for their preparation SI9300584A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929223445A GB9223445D0 (en) 1992-11-09 1992-11-09 Therapeutic agents
CN94105852A CN1113911A (zh) 1992-11-09 1994-05-07 治疗剂

Publications (1)

Publication Number Publication Date
SI9300584A true SI9300584A (en) 1994-06-30

Family

ID=37075771

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9300584A SI9300584A (en) 1992-11-09 1993-11-09 Therapeutic agents for treatment of obesity and affective disorders and processes for their preparation

Country Status (27)

Country Link
US (1) US5610161A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0667860B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH08502985A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1113911A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE169907T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU5338194A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG99608A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR9307388A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2148582A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ117595A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69320488T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0667860T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2118977T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI952205L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB9223445D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HR (1) HRP931384A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (2) HUT71554A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL107486A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN176828B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LT (1) LT3421B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX9306951A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO951798L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL308754A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SI (1) SI9300584A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (1) SK58995A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1994011346A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA938302B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3218540A1 (de) * 1982-05-17 1983-11-24 Hoechst Ag, 6230 Frankfurt Spiro-2-aza-alkan-3-carbonitrile, verfahren zu ihrer herstellung und ihre verwendung
US4430335A (en) * 1983-02-09 1984-02-07 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1-azaspiro[4,5]decanes and their analgesic compositions

Also Published As

Publication number Publication date
ES2118977T3 (es) 1998-10-01
GB9223445D0 (en) 1992-12-23
AU5338194A (en) 1994-06-08
BG99608A (bg) 1995-08-28
FI952205A0 (fi) 1995-05-08
DE69320488T2 (de) 1998-12-24
EP0667860B1 (en) 1998-08-19
US5610161A (en) 1997-03-11
WO1994011346A1 (en) 1994-05-26
FI952205A7 (fi) 1995-05-08
MX9306951A (es) 1995-01-31
NO951798L (no) 1995-05-31
ZA938302B (en) 1994-05-09
DK0667860T3 (da) 1999-05-25
IN176828B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1996-09-21
LTIP1450A (en) 1994-10-25
HRP931384A2 (en) 1994-12-31
HU211867A9 (en) 1995-12-28
FI952205L (fi) 1995-05-08
NO951798D0 (no) 1995-05-08
LT3421B (en) 1995-09-25
PL308754A1 (en) 1995-08-21
CZ117595A3 (en) 1995-12-13
BR9307388A (pt) 1999-08-31
EP0667860A1 (en) 1995-08-23
HU9501317D0 (en) 1995-06-28
DE69320488D1 (de) 1998-09-24
ATE169907T1 (de) 1998-09-15
SK58995A3 (en) 1995-10-11
IL107486A0 (en) 1994-02-27
CN1113911A (zh) 1995-12-27
CA2148582A1 (en) 1994-05-26
HUT71554A (en) 1995-12-28
JPH08502985A (ja) 1996-04-02

Similar Documents

Publication Publication Date Title
DE69524114T2 (de) Naphthyridinonderivate
US4207324A (en) 1,2-Di-Substituted-4-haloimidazole-5-acetic acid derivatives and their use
EP0289380B1 (fr) Dérivés d'aryl-hétéroaryl carbinols avec activité analgésique
US5464781A (en) Amino naphthyridine compounds as anti-rhoumatic agents
US6410582B1 (en) Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
LU85743A1 (fr) Composes heterocycliques
EP0172096A1 (fr) Dérivés d'acylaminométhyl-3 imidazo[1,2-a]pyridines, leur préparation et leur application en thérapeutique
CA1315793C (en) Method for controlling emesis caused by chemotherapeutic agents and antiemetic carboxamides useful therein
BE898278A (fr) Benzoxazines antipsychotiques.
HUP9904623A2 (hu) 1H-Pirido[3,4-b]indol-4-karboxamid-származékok,eljárás előállításukra és alkalmazásuk a gyógyászatban
EP0047536A2 (en) Substituted propylamines
HU184712B (en) Process for producing dextrorotating trans-2-substituted-5-phenyl-2,3,4,4a,5,9b,hexahydro-h-pyrido-bracket-4,3,b-bracket closedindol derivatives
DE69012650T2 (de) Piperidinderivat, Verfahren zur Herstellung davon und dieses enthaltende pharmazeutische Zusammensetzung.
GB2061274A (en) 3-benzoyl-2-nitrophenylacetic acids metal salts amides and esters
JPS6377856A (ja) 新規なフェニル、ピロリジン―2―イル置換5員複素環化合物およびその製造方法並びにこの化合物を有効成分とする抗精神病医薬組成物
FR2662442A1 (fr) Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant.
EP0061056A1 (de) 5,6-Dimethyl-pyrrolo(2,3-b)pyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
SI9300584A (en) Therapeutic agents for treatment of obesity and affective disorders and processes for their preparation
JPS62169791A (ja) ピロロ〔1,2−a〕〔4,1〕ベンゾオキサゼピン誘導体
DE69125569T2 (de) 8-Azabicyclo[3.2.1]octylalkylthiazolidinone, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CA1054597A (en) 1,6,7,8-tetrahydro-4-oxo-4h-pyrido (1,2-a) pyrimidine-9-carboalkoxy compounds
WO1995030676A1 (en) Antirheumatic 1-alkyl-4-hydroxy-3-(thien-3-yl) 1,8-naphthyridin-2(1h)-ones
US4443452A (en) Dibenzodiazepinones, pharmaceutical compositions thereof and method of use thereof
JPH0657656B2 (ja) 新規組成物
IL29176A (en) Benzylpyridinium compounds,their preparation and pharmaceutical preparations containing them